|Grant ID: R1207|
Recruitment of First-Time, Tenure-Track Faculty Members
January 18, 2012
One of the genes most frequently mutated in cancer, called RAS, which is found in more than 30 percent of all cancer types, has been under intense study for decades. It was one of the first cancer-causing genes discovered, but strategies for shutting it down have come up short, until recently.
Now a structural biologist, recruited in 2012 to the University of Texas Southwestern Medical Center from Harvard Medical School, is a crucial part of the effort to target mutated RAS genes in order to treat cancer. Dr. Kenneth Westover, M.D., Ph.D., was recruited with the help of a First-Time Tenure-Track Award from CPRIT. Dr. Westover has a dual role at UT Southwestern Medical Center, both as a research scientist and as a radiation oncologist who treats lung cancer patients.